XML 53 R38.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements (Tables)
12 Months Ended
Mar. 27, 2021
Fair Value Disclosures [Abstract]  
Fair value of financial assets and liabilities measured and recorded at fair value on recurring basis
The following table summarizes the Company's financial assets and liabilities that are measured and recorded at fair value on a recurring basis, excluding accrued interest components:
March 27,
2021
March 28,
2020
 (millions)
Investments in commercial paper(a)(b)
$— $243.6 
Derivative assets(a)
15.8 62.3 
Derivative liabilities(a)
55.4 6.9 
(a)Based on Level 2 measurements.
(b)Amounts are included within short-term investments in the consolidated balance sheet.
Carrying value and the estimated fair value of the Company's debt obligations
The following table summarizes the carrying values and the estimated fair values of the Company's debt instruments:
 March 27, 2021March 28, 2020
 
Carrying Value(a)
Fair Value(b)
Carrying Value(a)
Fair Value(b)
 (millions)
$300 million 2.625% Senior Notes$— $— $299.6 $299.8 
$400 million 3.750% Senior Notes397.1 443.4 396.4 415.1 
$500 million 1.700% Senior Notes498.4 507.8 — — 
$750 million 2.950% Senior Notes737.4 779.4 — — 
Borrowings outstanding under credit facilities— — 475.0 473.0 
 
(a)See Note 11 for discussion of the carrying values of the Company's senior notes.
(b)Based on Level 2 measurements.
Fair value measurements, nonrecurring
The following tables summarize non-cash impairment charges recorded by the Company during the fiscal years presented in order to reduce the carrying values of certain long-lived assets to their estimated fair values as of the assessment date:
Fiscal Years Ended
March 27, 2021March 28, 2020March 30, 2019
Long-Lived Asset CategoryFair Value
As of Impairment Date
Total Impairments(a)
Fair Value
As of Impairment Date
Total Impairments(a)
Fair Value
As of Impairment Date
Total Impairments(a)
 (millions)
Property and equipment, net(b)
$23.5 $44.1 $2.4 $16.8 $20.8 $25.8 
Operating lease right-of-use assets(c)
84.3 51.9 120.8 239.9 N/AN/A
Equity method investment
N/A— 1.3 7.1 N/A— 
 
(a)Impairment of equity method investment is recorded within other income (expense), net in the consolidated statements of operations. All other impairment charges are recorded within impairments of assets in the consolidated statements of operations, unless otherwise noted.
(b)Total impairment charges for Fiscal 2019 includes $4.6 million recorded to reduce the carrying value of the Company's corporate jet being held-for-sale to its estimated fair value, less costs to sell of $20.8 million as of March 30, 2019. This balance was reclassified from property and equipment, net to prepaid expenses and other current assets in the consolidated balance sheet upon being classified as an asset held-for-sale. The asset was subsequently sold during Fiscal 2020.
(c)Total impairment charges for Fiscal 2020 includes $225.1 million recorded in connection with the Company's adoption of ASU 2016-02 as of the beginning of Fiscal 2020 which, net of related income tax benefits, reduced its opening retained earnings balance by $169.4 million.